We are live on ! Find out more
PMVP icon

PMV Pharmaceuticals
PMVP

81 hedge funds and large institutions have $1.31B invested in PMV Pharmaceuticals in 2021 Q1 according to their latest regulatory filings, with 15 funds opening new positions, 32 increasing their positions, 20 reducing their positions, and 7 closing their positions.

New
Increased
Maintained
Reduced
Closed

114% more first-time investments, than exits

New positions opened: 15 | Existing positions closed: 7

60% more repeat investments, than reductions

Existing positions increased: 32 | Existing positions reduced: 20

11% more funds holding

Funds holding: 73 → 81 (+8)

3.78% more ownership

Funds ownership: 85.36% → 89.14% (+3.8%)

33% less funds holding in top 10

Funds holding in top 10: 6 → 4 (-2)

44% less capital invested

Capital invested by funds: $2.33B → $1.31B (-$1.02B)

Holders
81
Holders Change
+8
Holders Change %
+10.96%
% of All Funds
1.42%
Holding in Top 10
4
Holding in Top 10 Change
-2
Holding in Top 10 Change %
-33.33%
% of All Funds
0.07%
New
15
Increased
32
Reduced
20
Closed
7
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
JP Morgan Chase
JP Morgan Chase
New York
+$35.4M
2
PCS
Personal CFO Solutions
New Jersey
+$33.7M
3
State Street
State Street
Massachusetts
+$15.9M
4
DM
Deerfield Management
New York
+$9.32M
5
Jennison Associates
Jennison Associates
New York
+$8.26M

Top Sellers

Rank Fund Capital Flow
1
IVM
InterWest Venture Management
California
-$39.4M
2
Wellington Management Group
Wellington Management Group
Massachusetts
-$11.7M
3
Viking Global Investors
Viking Global Investors
Connecticut
-$10.9M
4
PA
Perceptive Advisors
New York
-$5.48M
5
Invesco
Invesco
Georgia
-$2.59M
Name Holding Trade Value Shares
Change 		Change in
Stake
WP
26
Woodline Partners
California
$7.36M -$44.6K -1,131 -0.5%
DCM
27
Driehaus Capital Management
Illinois
$7.08M -$651K -16,509 -7%
Franklin Resources
28
Franklin Resources
California
$6.58M – – –
LGM
29
Logos Global Management
California
$6.58M +$3.94M +100,000 +100%
Principal Financial Group
30
Principal Financial Group
Iowa
$6.53M +$77.5K +1,967 +1%
UBS AM
31
UBS AM
Illinois
$6.37M -$43.2K -1,097 -0.6%
Northern Trust
32
Northern Trust
Illinois
$5.32M +$219K +5,549 +4%
CC
33
Commodore Capital
New York
$4.11M – – –
T. Rowe Price Associates
34
T. Rowe Price Associates
Maryland
$3.93M +$4.71M +119,375 New
ACM
35
Asymmetry Capital Management
California
$3.88M +$849K +21,533 +22%
Charles Schwab
36
Charles Schwab
California
$2.8M +$75.7K +1,921 +2%
Goldman Sachs
37
Goldman Sachs
New York
$2.66M +$3.19M +80,861 New
Adage Capital Partners
38
Adage Capital Partners
Massachusetts
$2.56M +$3.07M +78,000 New
N
39
Nuveen
North Carolina
$2.03M +$467K +11,841 +24%
Deutsche Bank
40
Deutsche Bank
Germany
$1.72M +$474K +12,036 +30%
EC
41
EcoR1 Capital
California
$1.65M – – –
SFM
42
Sphera Funds Management
Israel
$1.43M +$1.71M +43,356 New
Bank of New York Mellon
43
Bank of New York Mellon
New York
$1.33M -$34.7K -881 -2%
Bank of America
44
Bank of America
North Carolina
$1.27M +$1.35M +34,300 +771%
B
45
BP
United Kingdom
$1.23M +$1.47M +37,262 New
Citigroup
46
Citigroup
New York
$1.09M +$1.2M +30,445 +1,182%
Prudential Financial
47
Prudential Financial
New Jersey
$1.06M +$1.27M +32,215 New
Rafferty Asset Management
48
Rafferty Asset Management
New York
$871K +$1.04M +26,472 New
California Public Employees Retirement System
49
California Public Employees Retirement System
California
$785K -$88.3K -2,239 -9%
MCCP
50
Mission Creek Capital Partners
California
$759K +$910K +23,077 New
1
2
3 4

PMVP Hedge Fund Activity: Q1 2021 in Review

81 of the 5,696 institutional investors tracked by Wall St. Rank reported a position in PMV Pharmaceuticals (PMVP) for Q1 2021, worth a combined $1.31B — down 44% from $2.33B a quarter earlier.

Buyers outnumbered sellers: 15 funds opened new PMVP positions and 7 closed out — a net gain of 8 holders — while 32 added to existing stakes and 20 trimmed.

The largest buyer was JP Morgan Chase, adding an estimated $35.4M. The largest seller was InterWest Venture Management, cutting an estimated $39.4M.

  • 81 institutional investors held PMV Pharmaceuticals (PMVP) as of Q1 2021, up from 73 in Q4 2020.
  • Funds reported $1.31B of PMV Pharmaceuticals stock for Q1 2021, down 44% quarter-over-quarter.
  • 15 funds opened new PMV Pharmaceuticals positions in Q1 2021 and 7 closed out, a net change of +8 holders.
  • The largest PMV Pharmaceuticals buyer in Q1 2021 was JP Morgan Chase, an estimated $35.4M added.
  • The largest PMV Pharmaceuticals seller in Q1 2021 was InterWest Venture Management, an estimated $39.4M sold.

Based on aggregated 13F filings for Q1 2021.